Latest Strategy Changes News

Investors in Fat Prophets Global Property Fund have voted to wind up the fund, initiating a formal closure process and delisting from the ASX.

Entyr Limited has ramped up tyre receivals and processing volumes in the December quarter, alongside securing new supply and offtake agreements as it prepares for ASX reinstatement. The company’s ongoing plant upgrades and strategic partnerships signal a potential turnaround in its operational and financial trajectory.

Xstate Resources reports steady oil and gas production while navigating ASX suspension and preparing for capital raising tied to a new project announcement.

Kaiser Reef Limited has made a pivotal advance by developing into the unmined Nova Zone at the A1 Gold Mine, marking a shift from remnant to modern mining operations, supported by a successful $8 million capital raise.

Stavely Minerals reported a $1.593 million net cash outflow for Q4 2024 but plans to reduce exploration expenditure in the coming quarter to preserve its $2.673 million cash balance.

Volt Resources exceeded its graphite production goals in Q4 2024, producing over 800 tonnes at its Ukrainian Zavalievsky mine, while progressing development of its Tanzanian Bunyu Graphite Project and refining a novel US-based purification process.

BauMart Holdings reports meaningful progress in expanding its distribution networks and strategic collaborations during the December 2024 quarter, positioning itself for growth across Indonesia, Australia, and the mining sector.

ReNu Energy has raised $500,000 through loan notes that may convert into shares and options pending shareholder approval, aiming to bolster working capital.

Viridis Mining and Minerals has delivered a maiden Mixed Rare Earth Carbonate product with exceptional recovery rates, alongside a substantial resource upgrade at its Colossus Rare Earth Project in Brazil.

FINEOS Corporation Holdings PLC reported a seasonal decline in cash balance and customer receipts in Q4 2024, while successfully onboarding new clients and maintaining a robust North American pipeline.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.